Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.

MLA

Yao, Amanda H., et al. “Metabolic Profiles of Individuals Switched to Second-Line Antiretroviral Therapy after Failing Standard First-Line Therapy for Treatment of HIV-1 Infection in a Randomized, Controlled Trial.” Antiviral Therapy, vol. 23, no. 1, 2018, pp. 21–32. EBSCOhost, https://doi.org/10.3851/IMP3171.

APA

Yao, A. H., Moore, C. L., Lim, P. L., Molina, J.-M., Madero, J. S., Kerr, S., Mallon, P. W., Emery, S., Cooper, D. A., & Boyd, M. A. (2018). Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial. Antiviral Therapy, 23(1), 21–32. https://doi.org/10.3851/IMP3171

Chicago

Yao, Amanda H, Cecilia L Moore, Poh Lian Lim, Jean-Michel Molina, Juan Sierra Madero, Stephen Kerr, Paddy Wg Mallon, Sean Emery, David A Cooper, and Mark A Boyd. 2018. “Metabolic Profiles of Individuals Switched to Second-Line Antiretroviral Therapy after Failing Standard First-Line Therapy for Treatment of HIV-1 Infection in a Randomized, Controlled Trial.” Antiviral Therapy 23 (1): 21–32. doi:10.3851/IMP3171.